Results 1 - 10 of 232
[RESULT IN BRIEF] Nanotechnology for cancer diagnosis and treatment.
Cancer remains the second most common cause of death in the EU despite recent significant advances. The development of more effective targeted therapies could dramatically improve the way we treat the disease.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[RESULT IN BRIEF] La nanotechnologie pour le diagnostic et le traitement du cancer
Le cancer reste la deuxième cause de décès dans l'UE malgré les progrès récents importants. Le développement de thérapies ciblées plus efficaces pourrait considérablement améliorer la manière dont nous traitons la maladie.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[RESULT IN BRIEF] Nanotechnologia w służbie diagnostyki i leczenia nowotworów złośliwych
Nowotwory złośliwe pozostają drugą co do częstości przyczyną śmierci w UE mimo ostatnich znaczących postępów wiedzy. Rozwój skuteczniejszych terapii celowanych może znacząco ulepszyć metody leczenia tej choroby.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[RESULT IN BRIEF] Nanotechnologie für die Diagnose und Behandlung von Krebs
Krebs bleibt trotz der jüngsten bedeutenden Fortschritte die zweithäufigste Todesursache in der EU. Die Entwicklung effektiver zielgerichteter Therapien könnte die Art, wie wir die Krankheit behandeln, erheblich verbessern.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[RESULT IN BRIEF] Nanotecnología aplicada al diagnóstico y tratamiento del cáncer
El cáncer es la segunda causa de muerte en la Unión Europea, a pesar de que recientemente se han realizado importantes avances. El desarrollo de terapias dirigidas más eficaces podría mejorar radicalmente el tratamiento de esta enfermedad.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[RESULT IN BRIEF] Le nanotecnologie per la diagnosi e il trattamento del cancro
Nonostante i recenti progressi, il cancro continua ad essere la seconda causa di morte nell’UE. Lo sviluppo di terapie più mirate potrebbe migliorare sensibilmente il modo in cui viene trattata questa malattia.
Programme: FP7-NMP
Record Number: 90668
Last updated on: 2016-04-22
[PROJECT] SAVEME - A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy
ID: 263307
Start date: 2011-03-01, End date: 2015-02-28
SaveMe project will address current urgent needs for pancreatic cancer diagnosis and treatment by exploiting partners’ expertise and most recent research achievements for the design and development of novel modular nanosystems platform integrating new functionalized nano-core...
Programme: FP7-NMP
Record Number: 98079
Last updated on: 2017-05-29
Executive Summary:Cancer is the second most common cause of death in the EU a figure that is expected to rise due to the ageing European population. Although significant advances are being made in the fight against the disease, cancer remains a key public health concern and a...
Programme: FP7-NMP
Record Number: 171728
Last updated on: 2015-10-15
[REPORT SUMMARY] Final Report Summary - MULTIFUN (Multifunctional Nanotechnology for selective detection and Treatment of cancer)
During the last four years the MULTIFUN consortium has focused its activity on the development and validation of new systems based upon minimal invasive nanotechnology for the early and selective detection and elimination of breast and pancreatic cancer. The...
Programme: FP7-NMP
Record Number: 182646
Last updated on: 2016-05-11
[REPORT SUMMARY] Final Report Summary - BACTERIOSAFE (Active wound dressings based on biological mimicry)
Executive Summary:The Bacteriosafe project developed responsive biocomposite materials and integrated them into sophisticated engineering processes for the manufacture of biologically active devices to potentially revolutionise burn treatment. We utilised the natural behaviour...
Programme: FP7-NMP
Record Number: 161159
Last updated on: 2015-04-23
List retrieved on: 2017-08-02
